Bendeka FDA Approved Drugs
BENDAMUSTINE HYDROCHLORIDE [Bendamustine HydrochlorideC16H21Cl2N3O2ClH]
RX
- 100mg/vial (iv (infusion) powder)
25mg/vial (iv (infusion) powder)
Accord HlthcareMay 19, 2016
Breckenridge PharmDec 29, 2016
Glenmark Pharms LtdMar 24, 2016
Hospira IncMay 20, 2016
Innopharma LicensingMar 24, 2016
Breckenridge PharmDec 29, 2016
Glenmark Pharms LtdMar 24, 2016
Hospira IncMay 20, 2016
Innopharma LicensingMar 24, 2016
BENDEKA [Bendamustine HydrochlorideC16H21Cl2N3O2ClH]
RX
- 100mg/4ml (25mg/ml) (iv (infusion) solution)
Eagle PharmsDec 7, 2015
- For the treatment of patients with chronic lymphocytic leukemia.
- For the treatment of patients with indolent b-cell non-hodgkin lymphoma.
- For use in the treatment of patients with chronic lymphocytic leukemia and/or non-hodgkins lymphoma.
- For use in treatment of patients with chronic lymphocytic leukemia (cll) and/or non-hodgkin's lymphoma.
TREANDA [Bendamustine HydrochlorideC16H21Cl2N3O2ClH]
RX
- 100mg/vial (iv (infusion) powder)
180mg/2ml (90mg/ml) (iv (infusion) solution)
25mg/vial (iv (infusion) powder)
45mg/0.5ml (90mg/ml) (iv (infusion) solution)
CephalonMar 20, 2008
- For use in the treatment of patients with chronic lymphocytic leukemia (cll) and/or indolent b-cell non-hodgkin lymphoma (nhl).
- For use in the treatment of patients with chronic lymphocytic leukemia (cll).
- For use in the treatment of patients with chronic lymphocytic leukemia and/or non-hodgkins lymphoma.
- For use in the treatment of patients with indolent b-cell non-hodgkin lymphoma.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.